These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 29750030)

  • 21. The cross-sectional and longitudinal association of the BODE index with quality of life in patients with chronic obstructive pulmonary disease.
    Lin YX; Xu WN; Liang LR; Pang BS; Nie XH; Zhang J; Wang H; Liu YX; Wang DQ; Xu ZY; Wang HW; Zhang HS; He ZY; Yang T; Wang C
    Chin Med J (Engl); 2009 Dec; 122(24):2939-44. PubMed ID: 20137478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adrenomedullin refines mortality prediction by the BODE index in COPD: the "BODE-A" index.
    Stolz D; Kostikas K; Blasi F; Boersma W; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Hertel S; Giersdorf S; Tamm M
    Eur Respir J; 2014 Feb; 43(2):397-408. PubMed ID: 23794469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a new parameter in the 6-minute walk test for manifold analysis of exercise capacity in patients with COPD.
    Ijiri N; Kanazawa H; Yoshikawa T; Hirata K
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1235-40. PubMed ID: 25395845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of electronic nose technology with spirometry: validation of a new approach for exhaled breath analysis.
    de Vries R; Brinkman P; van der Schee MP; Fens N; Dijkers E; Bootsma SK; de Jongh FH; Sterk PJ
    J Breath Res; 2015 Oct; 9(4):046001. PubMed ID: 26469298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The BODE index after lung volume reduction surgery correlates with survival.
    Imfeld S; Bloch KE; Weder W; Russi EW
    Chest; 2006 Apr; 129(4):873-8. PubMed ID: 16608932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD.
    Ong KC; Earnest A; Lu SJ
    Chest; 2005 Dec; 128(6):3810-6. PubMed ID: 16354849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BODE-index, modified BODE-index and ADO-score in chronic obstructive pulmonary disease: relationship with COPD phenotypes and CT lung density changes.
    Camiciottoli G; Bigazzi F; Bartolucci M; Cestelli L; Paoletti M; Diciotti S; Cavigli E; Magni C; Buonasera L; Mascalchi M; Pistolesi M
    COPD; 2012 Jun; 9(3):297-304. PubMed ID: 22432964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Detection of Early Lung Cancer in Patients With COPD in Regular Care by Electronic Nose Analysis of Exhaled Breath.
    de Vries R; Farzan N; Fabius T; De Jongh FHC; Jak PMC; Haarman EG; Snoey E; In 't Veen JCCM; Dagelet YWF; Maitland-Van Der Zee AH; Lucas A; Van Den Heuvel MM; Wolf-Lansdorf M; Muller M; Baas P; Sterk PJ
    Chest; 2023 Nov; 164(5):1315-1324. PubMed ID: 37209772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Electronic Noses in Phenotyping Patients with Chronic Obstructive Pulmonary Disease.
    Scarlata S; Finamore P; Meszaros M; Dragonieri S; Bikov A
    Biosensors (Basel); 2020 Nov; 10(11):. PubMed ID: 33187142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breath Testing for Barrett's Esophagus Using Exhaled Volatile Organic Compound Profiling With an Electronic Nose Device.
    Chan DK; Zakko L; Visrodia KH; Leggett CL; Lutzke LS; Clemens MA; Allen JD; Anderson MA; Wang KK
    Gastroenterology; 2017 Jan; 152(1):24-26. PubMed ID: 27825962
    [No Abstract]   [Full Text] [Related]  

  • 34. Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD?
    Ong KC; Lu SJ; Soh CS
    Int J Chron Obstruct Pulmon Dis; 2006; 1(1):91-6. PubMed ID: 18046907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breath profiles by electronic nose correlate with systemic markers but not ozone response.
    Biller H; Holz O; Windt H; Koch W; Müller M; Jörres RA; Krug N; Hohlfeld JM
    Respir Med; 2011 Sep; 105(9):1352-63. PubMed ID: 21439804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The modified BODE index: validation with mortality in COPD.
    Cote CG; Pinto-Plata VM; Marin JM; Nekach H; Dordelly LJ; Celli BR
    Eur Respir J; 2008 Nov; 32(5):1269-74. PubMed ID: 18579541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
    Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
    Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds.
    Basanta M; Ibrahim B; Douce D; Morris M; Woodcock A; Fowler SJ
    J Breath Res; 2012 Jun; 6(2):026002. PubMed ID: 22549110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between oxygen consumption kinetics and BODE Index in COPD patients.
    Borghi-Silva A; Beltrame T; Reis MS; Sampaio LM; Catai AM; Arena R; Costa D
    Int J Chron Obstruct Pulmon Dis; 2012; 7():711-8. PubMed ID: 23118534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Replacement of the 6-min walk test with maximal oxygen consumption in the BODE Index applied to patients with COPD: an equivalency study.
    Cardoso F; Tufanin AT; Colucci M; Nascimento O; Jardim JR
    Chest; 2007 Aug; 132(2):477-82. PubMed ID: 17505032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.